Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.
If I had clinically isolated syndrome with magnetic resonance imaging diagnostic of multiple sclerosis, I would take vitamin D 10,000 IU daily: Yes.
A population-based study of fall risk factors among people with multiple sclerosis in Stockholm county.
Rationale and design of a randomized controlled, clinical trial investigating a comprehensive exercise stimulus for improving mobility disability outcomes in persons with multiple sclerosis.
Cognitive functions in multiple sclerosis: impact of gray matter integrity.
Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis.
Proteinticle Engineering for Accurate 3D Diagnosis.
Cost effectiveness of a pragmatic exercise intervention (EXIMS) for people with multiple sclerosis: economic evaluation of a randomised controlled trial.
The antibody genetics of multiple sclerosis: comparing next-generation sequencing to sanger sequencing.
Botulinum Toxin Injection Techniques for Management of Adult Spasticity.
MRI relaxation in the presence of fictitious fields correlates with myelin content in normal rat brain.
Intracortical Posterior Cingulate Myelin Content Relates to Error Processing: Results from T1- and T2-Weighted MRI Myelin Mapping and Electrophysiology in Healthy Adults.
From the Cajal alumni Achúcarro and Río-Hortega to the rediscovery of never-resting microglia.
Autonomic dysfunction in multiple sclerosis.
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis.
Effect of fingolimod on cardiac autonomic regulation in patients with multiple sclerosis.
Use of a physiological profile to document motor impairment in ageing and in clinical groups.
Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.
Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling.
Episodic Mood Changes Preceding an Exacerbation of Multiple Sclerosis.
Dopaminergic D2-like agonists produce yawning in the myelin mutant taiep and Sprague-Dawley rats.
Predicting Breakdown of the Blood-Brain Barrier in Multiple Sclerosis without Contrast Agents.
Neurological perspectives on voltage-gated sodium channels.
Interleukin-10 Gene-transfected Mature Dendritic Cells Suppress Murine Experimental Autoimmune Optic Neuritis.
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes.
Pages
« first
‹ previous
…
456
457
458
459
460
461
462
463
464
…
next ›
last »